Therapeutic Advances in Psychopharmacology

Papers
(The TQCC of Therapeutic Advances in Psychopharmacology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?45
What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications39
Current antipsychotic agent use and risk of venous thromboembolism and pulmonary embolism: a systematic review and meta-analysis of observational studies29
Clozapine discontinuation withdrawal symptoms in schizophrenia29
Repetitive transcranial magnetic stimulation for major depressive disorder: basic principles and future directions28
Transcranial magnetic stimulation for post-traumatic stress disorder25
Clinical pharmacist interventions in elderly patients with mental disorders in primary care focused on psychotropics: a retrospective pre–post observational study24
History repeating: guidelines to address common problems in psychedelic science24
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review24
Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review24
Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders22
The role of lumateperone in the treatment of schizophrenia21
Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action20
Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review20
Cognitive effects of vortioxetine in older adults: a systematic review19
Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review18
Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review18
Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study18
Trends in benzodiazepine receptor agonists use and associated factors in the Belgian general older population: analysis of the Belgian health interview survey data17
Asenapine: an atypical antipsychotic with atypical formulations17
Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants16
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update15
Synthetic opioids: a review and clinical update15
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series14
Pathophysiology, prognosis and treatment of tardive dyskinesia14
Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate14
Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine12
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey12
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA12
Classic psychedelics, health behavior, and physical health11
The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics11
Liquorice for pain?11
Exercise interventions to reduce anxiety in mid-life and late-life anxiety disorders and subthreshold anxiety disorder: a systematic review11
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry10
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies10
Treatment strategies for clozapine-induced hypotension: a systematic review9
Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital9
Excess deaths in treatment-resistant depression9
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia9
Identification of clinical phenotypes in schizophrenia: the role of lurasidone9
0.76491689682007